MX9700828A - Analogos del acido aspartico como inhibidores de la enzima que convierte a la interleucina-1 beta. - Google Patents

Analogos del acido aspartico como inhibidores de la enzima que convierte a la interleucina-1 beta.

Info

Publication number
MX9700828A
MX9700828A MX9700828A MX9700828A MX9700828A MX 9700828 A MX9700828 A MX 9700828A MX 9700828 A MX9700828 A MX 9700828A MX 9700828 A MX9700828 A MX 9700828A MX 9700828 A MX9700828 A MX 9700828A
Authority
MX
Mexico
Prior art keywords
interleukin
converting enzyme
enzyme inhibitors
acid analogs
beta converting
Prior art date
Application number
MX9700828A
Other languages
English (en)
Other versions
MXPA97000828A (es
Inventor
Roland E Dolle
Todd L Graybill
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of MX9700828A publication Critical patent/MX9700828A/es
Publication of MXPA97000828A publication Critical patent/MXPA97000828A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/28Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/34Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen compuestos, composiciones y métodos para inhibir la actividad de la interleucina-1B proteasa. Los compuestos, acetamida a-sustituidas son de la formula (A), en la que: R2 = H o alquilo; R3 = halo, O(CO)0-1 arilo, OPOR4R5; (a), (b) donde R4 y R5 = arilo; R6 = H, arilo o aralquilo; R7 = seleccionado independientemente de R6, CF3 y CF2CF3; R1 = R6-CO, heteroaril-CO, heteroaralquil-CO y aminoácido.
MXPA/A/1997/000828A 1994-08-02 1997-01-31 Analogos del acido aspartico como inhibidores de la enzima que convierte a la interleucina-1 beta MXPA97000828A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/284,861 US5565430A (en) 1994-08-02 1994-08-02 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
US08284861 1994-08-02
PCT/US1995/009668 WO1996003982A1 (en) 1994-08-02 1995-07-31 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors

Publications (2)

Publication Number Publication Date
MX9700828A true MX9700828A (es) 1997-10-31
MXPA97000828A MXPA97000828A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
CA2196183A1 (en) 1996-02-15
AU684993B2 (en) 1998-01-08
NO970410D0 (no) 1997-01-30
AU3235495A (en) 1996-03-04
FI970430A (fi) 1997-04-01
FI970430A0 (fi) 1997-01-31
US5565430A (en) 1996-10-15
EP0767661A1 (en) 1997-04-16
WO1996003982A1 (en) 1996-02-15
JPH10504816A (ja) 1998-05-12
EP0767661A4 (en) 1998-06-10
NO970410L (no) 1997-03-07

Similar Documents

Publication Publication Date Title
NO970410L (no) Azaasparaginsyreanaloger som inhibitorer av interleukin-1 <beta> omdannende enzym
MX9703564A (es) Inhibidores de proteasa multicatalitica.
NO941580D0 (es)
IL128666A (en) Substituted cyclic amine metalloprotease inhibitors
CA2264254A1 (en) Phosphinic acid amides as matrix metalloprotease inhibitors
BG103415A (en) Heteroaryl succinamides and their application as inhibitors of metalloproteinase
MX9701893A (es) Nuevos inhibidores de la prostaglandinsintasa.
DE69711391D1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
AU1026599A (en) Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
GR3026556T3 (en) Peptidic ketones as interleukin-1beta-converting enzyme inhibitors.
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
HU9204029D0 (en) Proteolytic enzym inhibitors
FI942625A0 (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
MX9605196A (es) Halometilamidas como inhibidores de la proteasa il-1b.
PL325954A1 (en) Guanidinic protease inhibitors
HK1028028A1 (en) Substituted heterocyclic compounds, method for preparing and compositions containing same
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
MX9605737A (es) Transfeccion de celulas.
YU28902A (sh) Fenil- i piridil-tetrahidro-piridini koji imaju tnf-inhibitorsku aktivnost
IE810260L (en) Benzylidene derivatives.
EP0316907A3 (en) Enzyme inhibitor and method of producing the same
ES8703455A1 (es) Procedimiento para preparar n-(-(1'-alil-2'-pirrolidinil)- metil)-2-metoxi-4,5-azimido-benzamida a escala industrial
MX9704968A (es) Inhibidores que contienen acido hidroxamico de metaloproteasas de matriz.
ES8404827A1 (es) Procedimiento para la obtencion de compuestos de acido fenoxialcanoico.
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates